| Group | Value | 95% CI |
|---|---|---|
| Risk Display Format:Risk Ladder:Imagery Behavior:Exercise | 92.2 | ± 12.7 |
| Risk Display Format:Risk Ladder:Imagery Behavior:Sleep | 37.5 | ± 13.4 |
| Risk Display Format:Table:Imagery Behavior:Exercise | 63.1 | ± 12.4 |
| Risk Display Format:Table: Imagery Behavior:Sleep | 60.0 | ± 12.9 |
| Risk Display Format:Text:Imagery Behavior:Exercise | 50.1 | ± 12.5 |
| Risk Display Format:Text:Imagery Behavior:Sleep | 49.3 | ± 13.0 |
Last reviewed · How we verify
NCT03255291
Communicating Multiple Disease Risks: A Translation of Risk Prediction Science
NA trial testing Risk Assessment App in Healthy Volunteers in 554 participants. Completed in 3 January 2019.
3 January 2019
Quick facts
| Lead sponsor | Washington University School of Medicine |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | factorial |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 554 |
| Start date | 27 June 2017 |
| Primary completion | 3 January 2019 |
| Estimated completion | 3 January 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Risk Assessment App
- Audio Recording - Sleep
- Surveys
- Audio Recording - Exercise
- Text message reminders
- Text Message Survey
Conditions studied
- Healthy Volunteers — all drugs for Healthy Volunteers →
Sponsor
Washington University School of Medicine
Who can join
Adults 30 to 64, any sex, with Healthy Volunteers. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
* Risk display format = risk ladder, table, or text * Gist comprehension of risk information: being able to extract the bottom-line meaning of information provided by the website (e.g., if exercising decreased heath risk) * Measured by the sum of (4) questions coded as correctly comprehending risk information (1 point) or incorrectly comprehending risk information (0 points), with a total score range of 0=low comprehension to 4=high comprehension. Higher comprehension is considered a better outcome. * All comprehension questions have an additional "don't know" option, which is counted as incor
| Group | Value | 95% CI |
|---|---|---|
| Risk Display Format: Risk Ladder | 3.6 | ± 0.1 |
| Risk Display Format: Table | 3.4 | ± 0.1 |
| Risk Display Format: Text | 3.2 | ± 0.1 |
* Risk communication strategy = risk ladder, table, or text * Verbatim comprehension of risk information: being able to recall the exact information specific to diabetes risk and hours of recommended weekly physical activity * Measured by the sum of (3) questions coded as correctly comprehending information (1 point) or incorrectly comprehending information (0 points), with a total score range of 0=low comprehension to 3=high comprehension. Higher comprehension is considered a better outcome. * All comprehension questions have an additional "don't know" option, which is counted as incorrect. *
| Group | Value | 95% CI |
|---|---|---|
| Risk Display Format: Risk Ladder | 1.6 | ± 0.1 |
| Risk Display Format: Table | 1.6 | ± 0.1 |
| Risk Display Format: Text | 1.5 | ± 0.1 |
* Risk display format = risk ladder, table, or text * Self-reported physical activity intentions is defined as intentions to engage in physical activity in the next 3 months * Measured as an average of three variables, each measured on a 5 point Likert Scale (range: 1=lower intentions to 5=higher intentions) * Higher intentions are considered a better outcome
| Group | Value | 95% CI |
|---|---|---|
| Risk Display Format: Risk Ladder | 3.9 | ± 0.1 |
| Risk Display Format: Table | 4.0 | ± 0.1 |
| Risk Display Format: Text | 3.8 | ± 0.1 |
* Maintenance Self-efficacy is defined as being sure one can engage in physical activity even when it is hard * Measured on a 4 point Likert Scale (range: 1=lower Maintenance Self-efficacy to 4=higher Maintenance Self-efficacy) * Higher maintenance self-efficacy is considered a better outcome * Note: to limit participant burden, the investigators used a single item instead of averaging across multiple items
| Group | Value | 95% CI |
|---|---|---|
| Mental Imagery Behavior: Exercise | 2.95 | ± 0.05 |
* Recovery Self-efficacy is defined as being sure one can re-engage in physical activity after putting it off * Measured on a 4 point Likert Scale (range: 1=lower recovery Self-efficacy to 4=higher recovery Self-efficacy) * Higher recovery self-efficacy is considered a better outcome * Note: to limit participant burden, the investigators used a single item instead of averaging across multiple items
| Group | Value | 95% CI |
|---|---|---|
| Mental Imagery Behavior: Exercise | 3.26 | ± 0.05 |
* Affective Attitudes to Exercise - Enjoying Behavior is defined as thinking getting regular exercise is enjoyable * Measured on a 4 point Likert Scale (range: 1=lower Affective Attitudes to Exercise to 4=higher Affective Attitudes to Exercise) * Higher Affective Attitudes to Exercise - Enjoying Behavior is considered a better outcome * Note: to limit participant burden, the investigators used a single item instead of averaging across multiple items
| Group | Value | 95% CI |
|---|---|---|
| Mental Imagery Behavior: Exercise | 3.05 | ± 0.05 |
* Affective Attitudes to Exercise - Thinking Behavior is Unpleasant is defined as not thinking getting regular exercise is unpleasant * Measured on a 4 point Likert Scale (range: 1=lower Affective Attitudes to Exercise to 4=higher Affective Attitudes to Exercise) * Higher Affective Attitudes to Exercise - Thinking Behavior is Unpleasant is considered a better outcome * Note: to limit participant burden, the investigators used a single item instead of averaging across multiple items
| Group | Value | 95% CI |
|---|---|---|
| Mental Imagery Behavior: Exercise | 3.19 | ± 0.05 |
* Perceived Vividness of Self-regulatory Imagery is defined as having clear and vivid images of steps towards getting physical activity * Measured as an average of two variables measured on a 4 point Likert Scale (range: 1=lower Perceived Vividness of Self-regulatory Imagery to 4=higher Perceived Vividness of Self-regulatory Imagery) * Higher Perceived Vividness of Self-regulatory Imagery is considered a better outcome * Note: to limit participant burden, the investigators used a single item instead of averaging across multiple items
| Group | Value | 95% CI |
|---|---|---|
| Mental Imagery Behavior: Exercise | 3.36 | ± 0.04 |
* Action planning is defined as having a detailed plan about getting adequate physical activity * Measured as an average of three variables measured on a 4 point Likert Scale (range: 1=lower action planning to 4=higher action planning) * Higher action planning is considered a better outcome * Note: to limit participant burden, the investigators used a single item instead of averaging across multiple items
| Group | Value | 95% CI |
|---|---|---|
| Mental Imagery Behavior: Exercise | 3.52 | ± 0.03 |
* Coping planning is defined as having a detailed plan of solving problems that may prevent getting adequate physical activity * Measured on a 4 point Likert Scale (range: 1=lower Coping Planning to 4=higher Coping Planning) * Higher coping planning is considered a better outcome * Note: to limit participant burden, the investigators used a single item instead of averaging across multiple items
| Group | Value | 95% CI |
|---|---|---|
| Mental Imagery Behavior: Exercise | 2.98 | ± 0.04 |
* Action self-efficacy is defined as having the confidence to engage in physical activity * Measured on a 4 point Likert Scale (range: 1=lower Action Self-efficacy to 4=higher Action Self-efficacy) * Higher Action Self-efficacy is considered a better outcome * Note: to limit participant burden, the investigators used a single item instead of averaging across multiple items
| Group | Value | 95% CI |
|---|---|---|
| Mental Imagery Behavior: Exercise | 3.36 | ± 0.04 |
Sponsor's own description
Epidemiology seeks to improve public health by identifying risk factors for cancer and other diseases and conveying that information to relevant audiences (e.g., physicians, the public). The audience is presumed to understand and use that information to make appropriate decisions about lifestyle behaviors and medical treatments. Yet, even though a single risk factor can affect the risk of multiple health outcomes, this information is seldom communicated to people in a way that optimizes their understanding of the importance of engaging in a single healthy behavior. Providing individuals with the ability to understand how a single behavior (obtaining sufficient physical activity) could affect their risk of developing multiple diseases could foster a more coherent and meaningful picture of the behavior's importance in reducing health risks, increase motivation and intentions to engage in the behavior, and over time improve public health. The proposed study translates epidemiological data about five diseases that cause significant morbidity and mortality (i.e., colon cancer, breast cancer (women), heart disease, diabetes, and stroke) into a visual display that conveys individualized risk estimates in a comprehensible, meaningful, and useful way to diverse lay audiences.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Risk Ladder, Table, or Bulleted List? Identifying Formats That Effectively Communicate Personalized Risk and Risk Reduction Information for Multiple Diseases.
Waters EA, Maki J, Liu Y, Ackermann N, et al · · 2021 · cited 14× · PMID 33106087 · DOI 10.1177/0272989x20968070 -
Mental imagery-based self-regulation: Effects on physical activity behaviour and its cognitive and affective precursors over time.
Ackermann N, Cameron LD, Maki J, Carter CR, et al · · 2022 · cited 4× · PMID 34523193 · DOI 10.1111/bjhp.12558
Verify or expand the search:
- PubMed search for NCT03255291
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Healthy Volunteers
Currently open trials in the same condition.
- NCT07504003 — Influence of Training Session Duration on Improvements in Physiological Resilience to Exercise · NA · recruiting
- NCT07446400 — A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuva · Phase 1 · recruiting
- NCT07495813 — A Study to See How RO7763505 Works and How Safe it is When Given to Healthy People and People With Stable Heart Disease · Phase 1 · recruiting
- NCT07499050 — A Study of Multiple Doses of Orally Administered RO7795081 in Otherwise Healthy Chinese Adult Participants With Obesity · Phase 1 · recruiting
- NCT07342114 — A Dose-Escalation Study of RO7875913 in Healthy Participants · Phase 1 · recruiting
Other Washington University School of Medicine trials
Trials by the same sponsor.
- NCT05521997 — Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer · Phase 2 · not yet recruiting
- NCT07101666 — Total Neoadjuvant Therapy With Short Course Radiation Therapy in Gastric Cancer · Phase 2 · not yet recruiting
- NCT07200089 — Recombinant Human IL-7 (NT-I7) in Relapsed/Refractory Multiple Myeloma Following BCMA CAR-T Therapy (Cilta-cel) · Phase 1 · not yet recruiting
- NCT07313592 — Whole Genome Sequencing (ChromoSeq®) for Acute Lymphoblastic Leukemia (ALL) Patients · not yet recruiting
- NCT07419464 — 5-Fluorouracil Response and Optimization STudy (The FROST Trial) · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03255291 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Washington University School of Medicine
- Last refreshed: 18 January 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03255291.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing